Later studies showed that CD248 expression was also upregulated specifically in liver fibrosis, and CD248 was expressed mainly in activated HSCs, but not in quiescent HSCs, indicating that CD248 could be an effective therapeutic target for liver fibrosis (Wilhelm et al. 2016). Here, CD248 is linked to Hepatic fibrosis.